Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,187 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06524960RecruitingPhase 1/Phase 2
Denosumab for Preserving Insulin in Type 1 Diabetes
This study tests if denosumab, a drug normally used for bone health, can help preserve your body's own insulin production in type 1 diabetes. It might slow the loss of insulin-making cells, helping you maintain better blood sugar control over time.
Birmingham, AlabamaAges 18–50 - NCT06525259Recruiting
Study on risk factors for type 2 diabetes in youth
This study looks for children and teens who are at high risk of developing type 2 diabetes to understand what factors lead to it. If your child is overweight, has slightly high blood sugar, and is in early to mid-puberty, they may be able to join.
Birmingham, AlabamaAges 8–15 - NCT06542627Recruiting
Continuous glucose monitoring for diabetes and weight management
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
SeoulAges 19 years+ - NCT06562842Recruiting
Exercise, Gut Health, and Type 2 Diabetes Study
This study looks at how exercise affects gut bacteria in people with type 2 diabetes. It may help explain why physical activity improves diabetes control.
TrikalaAges 45–65 - NCT06570980Recruiting
Comparing two diabetes drugs taken with metformin
This study looks at two common diabetes pills (sulfonylureas and DPP4 inhibitors) when used together with metformin. It aims to find out which combination is more cost-effective for treating type 2 diabetes.
DhakaAges 18 years+ - NCT06575842Recruiting
Accuracy of glucose monitors during surgery in youth with type 1 diabetes
This trial tests how well continuous glucose monitors (CGMs) work during surgery and hospital stays in young people with type 1 diabetes. It aims to make sure these devices give accurate readings when they are most needed.
Aurora, ColoradoAges 2–26 - NCT06588894Recruiting
Motor imagery and body awareness in type 2 diabetes
This study looks at how well people with type 2 diabetes can imagine movements, sense their body, and think clearly. It aims to understand how these abilities are affected by diabetes.
Kütahya, CentralAges 18–65 - NCT06596967RecruitingPhase 1
Heat therapy for type 2 diabetes
This study tests if heat therapy can help older adults with type 2 diabetes manage their condition. You will be asked to wear a special garment that circulates warm water to raise your body temperature safely.
West Lafayette, IndianaAges 55 years+ - NCT06600555Recruiting
Metabolic surgery for diabetes control
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
VilleurbanneAges 18–65 - NCT06937203RecruitingPhase 1/Phase 2
A new obesity drug study for people with or without type 2 diabetes
This early-stage study tests an investigational drug called ARO-ALK7 to see if it helps adults with obesity lose weight. It includes people who have type 2 diabetes as well as those who do not, and requires that you have tried to lose weight with lifestyle changes in the past.
Morayfield, QLCAges 18–65 - NCT06694558Recruiting
Monocytes in type 1 diabetes and kidney disease study
This study looks at immune cells (monocytes) in people with type 1 diabetes, with or without early kidney problems. Researchers want to understand how these cells differ between groups. You may be able to join if you have type 1 diabetes and use an insulin pump or injections along with a continuous glucose monitor (CGM).
Cleveland, OhioAges 18–65 - NCT06613854RecruitingPhase 4
Early combination therapy for type 2 diabetes
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
LjubljanaAges 18–70 - NCT06627322Recruiting
Diabetes type 2 trial for people with heart risks
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
DaeguAges 19 years+ - NCT06628453Recruiting
Continuous glucose monitor for type 2 diabetes in pregnancy
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
Birmingham, AlabamaAges 18–50 - NCT06639425Recruiting
Testing a probiotic for newly diagnosed type 2 diabetes
This study tests whether a probiotic called Lactobacillus Paracasei LC19 can help control blood sugar in people who have just been diagnosed with type 2 diabetes and are not on any diabetes medications. It may be a natural way to manage the condition.
Beijing, Beijing MunicipalityAges 18–65 - NCT06642623RecruitingPhase 4
Study on heart and kidney health in type 2 diabetes
This trial tests enavogliflozin (a newer SGLT2 inhibitor) compared to older drugs (dapagliflozin or empagliflozin) to see how well it protects the heart and kidneys in people with type 2 diabetes.
SeoulAges 19 years+ - NCT06647550RecruitingPhase 2
Testing a new pill for type 2 diabetes not well controlled by diet and exercise
This trial tests a new medication, HD-6277, to see if it can help lower blood sugar in adults with type 2 diabetes that isn't well managed by diet and exercise alone.
SeoulAges 19–75 - NCT06649162Recruiting
Fatty liver risk in type 2 diabetes and new combo therapy
This study is looking at how often people with type 2 diabetes also have fatty liver disease, and whether a new combination medication (dapagliflozin and pioglitazone) can help manage both conditions.
Andong, Gyeongsangbuk-doAges 19 years+ - NCT06706284RecruitingPhase 4
GLP-1 agonist for diabetes after spinal cord injury
This trial tests whether a GLP-1 agonist (a type of diabetes medicine that also helps with weight loss) is safe and effective for people with spinal cord injury and type 2 diabetes who are not on other glucose-lowering drugs.
San Antonio, TexasAges 18–70 - NCT06716203RecruitingPhase 3
Study of BGM0504 for type 2 diabetes not well controlled by diet and exercise
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
Beijing, Beijing MunicipalityAges 18–75 - NCT06716216RecruitingPhase 3
Study of BGM0504 for people with type 2 diabetes
This trial tests an investigational drug called BGM0504 in people with type 2 diabetes who are already taking metformin or metformin plus another diabetes medicine. It aims to see if the drug can help lower blood sugar levels.
Beijing, Beijing MunicipalityAges 18–75 - NCT06727409RecruitingPhase 4
Triple therapy for type 2 diabetes and kidney disease
This study tests whether adding a non-steroidal mineralocorticoid antagonist to your current type 2 diabetes and kidney disease medications (SGLT2i and ACEi/ARB) is cost-effective. It may help preserve kidney function and reduce heart risks.
Hong KongAges 18 years+ - NCT06734546Recruiting
Exercise and brain health in type 2 diabetes
This study tests whether regular exercise can improve brain health in people with type 2 diabetes. If you have type 2 diabetes, are not on insulin, are inactive, and are between 30 and 75 years old, you may be able to join.
Hasselt, LimburgAges 30–75 - NCT06739122RecruitingPhase 3
A study of dulaglutide for children with type 2 diabetes
This trial tests if a weekly injection of dulaglutide (Trulicity) can help children with type 2 diabetes control their blood sugar when used together with metformin and/or insulin. It may be an option for kids who are overweight.
Tucson, ArizonaAges 10–17
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,187 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.